Oura Agrees to Acquire Counsel Health for $625 Million, Bringing AI and Physician Care Closer to Wearable Technology

From tracking health to helping people act on it

Wearable technology has made it easier for people to monitor their sleep, activity, heart rate and other physiological signals. But understanding what those measurements mean—and deciding what to do next—can be more complicated.

Oura is taking a significant step toward addressing that challenge.

On November 10, 2026, the smart-ring company announced a definitive agreement to acquire Counsel Health, an AI-enabled primary-care company, for $625 million in cash.

The proposed acquisition brings together two areas of healthcare innovation: continuous biometric monitoring and digital medical services.

The companies intend to create a more connected experience in which users can move from reviewing health information to seeking medical guidance through the same platform.

The transaction is expected to close before the end of 2026, subject to customary conditions.

What Counsel Health brings to Oura

Counsel Health combines a conversational AI interface with access to licensed physicians.

Its platform is designed to help patients ask health-related questions and obtain medical guidance, with physicians available when clinical expertise is required.

Potential needs include understanding laboratory results, discussing symptoms, obtaining prescriptions when appropriate and navigating referrals or ongoing care.

Oura and Counsel were already working together before the acquisition announcement. Their collaboration began earlier in 2026, giving the companies experience connecting wearable data with digital care.

The proposed acquisition would bring Counsel’s capabilities directly into Oura’s broader business.

However, access to particular services may depend on eligibility, geographic availability, clinical appropriateness and future product integration.

Why wearable health data matters

Wearable devices can provide information about physiological patterns over time.

Oura’s ring monitors signals associated with sleep, activity, stress, readiness and other aspects of health.

These measurements may help users recognize changes that deserve attention.

But a change in a wearable metric does not automatically indicate a medical condition.

Factors such as activity, sleep habits, illness, medication and individual physiology can influence measurements.

That distinction becomes especially important when health data is connected to AI-powered medical guidance.

The potential value lies in helping users interpret information within a broader clinical context—not treating wearable measurements as definitive diagnoses.

The role of physicians in AI-powered care

One of the defining features of Counsel’s model is its combination of AI technology and human clinicians.

AI systems can help organize information, provide explanations and support certain administrative or informational interactions.

Licensed physicians remain responsible for clinical judgments that require professional medical expertise.

This hybrid approach may become increasingly relevant as healthcare companies develop more sophisticated digital services.

However, AI systems can generate inaccurate or incomplete recommendations. Reliable clinical oversight, patient consent and appropriate escalation to human professionals remain essential.

Oura and Counsel will need to demonstrate that their combined experience can maintain those safeguards as the platform expands.

A major financial commitment to digital healthcare

The $625 million acquisition agreement follows a period of substantial growth reported by Oura.

For its fiscal fourth quarter ended September 30, 2026, the company reported revenue of approximately $533 million, representing 153% year-over-year growth.

Oura also reported approximately $1.75 billion in fiscal-year revenue.

These figures were described as preliminary and unaudited in the company’s announcement.

The acquisition reflects Oura’s strategy to develop services beyond the sale of wearable devices, potentially creating a more comprehensive health technology platform.

Whether that strategy succeeds will depend on user adoption, clinical quality, regulatory considerations and the economics of delivering medical services.

Opportunities for women in digital health and STEM

The convergence of wearable technology and medical AI creates opportunities across several disciplines.

Biomedical engineers help develop sensing systems and evaluate their performance.

Data scientists and AI researchers contribute to the analysis of complex health information.

Clinicians, clinical researchers and regulatory specialists help ensure technologies are evaluated responsibly.

Product designers, privacy professionals and healthcare strategists play important roles in making these systems accessible and trustworthy.

For women pursuing careers in STEM, digital health represents an intersection of engineering, clinical science, technology and business innovation.

It also creates opportunities to influence how products address different physiological needs and how health technologies are tested across diverse populations.

The privacy questions ahead

Continuous health monitoring can involve sensitive personal information.

Connecting that information with medical services raises questions about data access, consent, security and how information may be shared between systems.

Users will need clear explanations of which data is used, how it supports care and what choices they have.

The companies will also need to ensure that AI-generated information does not create misleading impressions of medical certainty.

These considerations are not secondary to the technology. They are central to whether users and clinicians can trust it.

What happens next?

Oura expects the acquisition to close before the end of 2026, assuming the required conditions are satisfied.

The companies plan to expand their connected-care experience, including preventive, acute and chronic care applications.

The announcement does not establish that all proposed services are already available to every Oura member.

For the digital health industry, the transaction represents an important strategic development.

Wearable devices are evolving from tools that primarily display measurements toward platforms that may help people access professional guidance.

The challenge will be making that experience clinically reliable, accessible and secure.

Sources and further reading

• Counsel Health and Oura — Official acquisition announcement, November 10, 2026
• Reuters — Oura to acquire Counsel Health for $625 million
• TechCrunch — Oura’s acquisition and digital healthcare strategy

Looking for Your Next Opportunity in STEM?

Explore emerging technologies, career developments and opportunities across the innovation economy through Fems in STEM Career Connections.

Subscribe to Fems in STEM Career Connections and visit femsinstem.com for more stories about the people and technologies shaping the future.

This article is independent editorial coverage based on publicly available information. It is not sponsored by or affiliated with the companies mentioned. It is not medical advice.